Skip to main content
main-content

Diabetes complications and comorbidities

Feature content

12-14-2018 | Risk factors | Feature | Article

Sleep duration: Waking up to a major metabolic risk factor

The effect of sleep duration on glucose regulation and cardiometabolic risk is becoming an increasingly high-profile issue. medwireNews takes a look at the latest evidence, which shows the gravity of the problem but also offers some solutions.

12-14-2018 | Sleep apnea | Editorial | Article

Diabetes and obstructive sleep apnea syndrome: Double trouble

Obstructive sleep apnea syndrome is a common and potentially serious comorbidity in people with diabetes and obesity. John Wilding highlights what you need to know about the condition.

Author:
John Wilding

12-05-2018 | Diabetes distress | Editorial | Article

Diabetes distress: What’s in a name?

Sanjay Kalra and Psychiatrist Yatan Pal Singh Balhara question whether “diabetes distress” is well understood outside of the diabetes field and consider whether alternative terminology may help to bridge the knowledge gap.

Authors:
Sanjay Kalra, Yatan Pal Singh Balhara

11-28-2018 | SGLT2 inhibitors | Commentary | Article

Expert commentary

What can real-world studies really tell us about amputation risk for SGLT2 inhibitors?

John Wilding considers the real-world studies examining the association between SGLT2 inhibitors and amputation risk in patients with type 2 diabetes.

Author:
John Wilding

11-28-2018 | SGLT2 inhibitors | At a glance | Article

Real-world studies of SGLT2 inhibition and amputation risk

How many real-world studies have looked at amputation risk in users of SGLT2 inhibitors, and do the findings support or refute the effect found in CANVAS? medwireNews rounds up the research so far.

10-24-2018 | Diabetes distress | Editorial | Article

Feeling stressed out and not meeting goals: A vicious cycle impacting diabetes self-management

Clinical psychologists Diana Naranjo and Korey Hood tackle the negative feedback loops that can develop around diabetes self-management and offer their insights on strategies to identify and address the roots of distress.

Authors:
Diana M. Naranjo, Korey K. Hood

09-30-2018 | Glycemic control | Clinical trial summary slides | Collection

10-year follow-up of intensive glucose control in type 2 diabetes

This slide set outlines the results of a 10-year, postinterventional follow-up of the UKPDS survivor cohort which examined whether a continued microvascular benefit from earlier improved glucose control was evident and whether such therapy had a long-term effect on macrovascular outcomes.

09-30-2018 | Medications | Clinical trial summary slides | Collection

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

This slide set outlines the results of the UKPDS33 study which compared the effects of intensive blood-glucose control with either sulfonylurea or insulin and conventional treatment on the risk of microvascular and macrovascular complications in patients with type 2 diabetes.

09-30-2018 | Metformin | Clinical trial summary slides | Collection

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

This slide set outlines the results of the UKPDS34 study which investigated whether intensive glucose control with metformin had any specific advantage or disadvantage in patients with type 2 diabetes.

09-30-2018 | Hypertension | Clinical trial summary slides | Collection

Long-term follow-up after tight control of blood pressure in type 2 diabetes

This slide set outlines the results of the post-trial monitoring of UKPDS which examined whether risk reductions for microvascular and macrovascular disease, achieved with the use of improved blood-pressure control during the trial, were sustained.

09-30-2018 | Complications | Slideset | Collection

UKPDS clinical trial summary slides

A collection of downloadable PowerPoint slides summarizing the primary and follow-up UKPDS findings. The aim of the UKPDS was to determine the effect of intensive glycemic control on the incidence of complications in patients with type 2 diabetes.

09-18-2018 | Sexual dysfunction | View from the clinic | Article

Regaining sexual health in diabetes: Start with open communication

Advisory Board member Clipper Young recounts an experience of starting a patient with erectile dysfunction on the path to appropriate treatment for him and his diabetes.

Author:
Clipper Young

09-12-2018 | Diet | Commentary | Article

Diet–drug interactions: Why two rights can make a wrong

Editorial Board member and Endocrinologist, Sanjay Kalra comments on the issues raised by a clinical case involving sodium glucose cotransporter 2 inhibitor therapy alongside a restrictive diet.

Author:
Sanjay Kalra

09-05-2018 | Diagnosis | Case study | Article

Acute illness while on a SGLT2 inhibitor and ketogenic diet

Advisory Board member Theresa Smyth tackles an emergency case in a type 2 diabetes patient treated with empagliflozin. What went wrong and how should he be managed?

Author:
Theresa Smyth

08-29-2018 | Blood glucose monitoring | Editorial | Article

The ambulatory glucose profile: What, why, and how?

Editorial Board member Lori Berard discusses how the ambulatory glucose profile is quietly revolutionizing the analysis of blood glucose and glycemic control for patients and practitioners.

Author:
Lori Berard

08-15-2018 | Neuropathy | Editorial | Article

Are we using the right tests to diagnose diabetic neuropathy?

Uazman Alam and colleagues interrogate current evidence and real-world clinical scenarios to address whether enough is being done with the tools available to screen and diagnose diabetic neuropathy.

Authors:
Shazli Azmi, Andrew Marshall, Andrew Nelson, Uazman Alam

07-04-2018 | Transitions of care | View from the clinic | Collection

Best communication practices for subspecialty referrals

Jay Shubrook draws on his experiences as a primary care physician and diabetes specialist to provide simple tips to help each profession optimize the patient referral process.

06-06-2018 | Insulin | View from the clinic | Audio

Barriers to insulin: Initiation in type 2 diabetes patients

Editorial Board member Lori Berard talks through the stages and challenges associated with preparing type 2 diabetes patients for insulin therapy (9:00).

05-30-2018 | Insulin | Editorial | Article

Hit early, hit hard: The EADSG insulin guidelines

Sanjay Kalra and Silver Bahendeka, East Africa Diabetes Study Group Chair, provide an overview of the latest insulin guidance developed to aid management in a challenging region, facing familiar struggles.

Authors:
Sanjay Kalra, Silver Bahendeka

05-09-2018 | Diagnosis | Case study | Article

Atypical diabetes: Case study 4

Can you diagnose the atypical form of diabetes presented in our fourth patient case study? Test your knowledge with Editorial Board member, Jay Shubrook.

Author:
Jay Shubrook
image credits